This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
Alpelisib is an alpha-selective PI3K inhibitor. In combination with fulvestrant, it prolongs progression-free survival in postmenopausal women, and men, with HR+/HER2–, PIK3CA-mutated, advanced or...
Women's Health is an up-to-date review to understand the broad perspectives of applications of OCPs and provide an understanding of the gradual transition of menopause, a critical phase of a...
Nachdem Guselkumab (TREMFYA®) für die Behandlung von Erwachsenen mit mittelschwerer bis schwerer Plaque-Psoriasis, die für eine systemische Therapie infrage kommen, bereits seit November 2017...
One of our ophthalmologist Members recently contacted us about an unusual request from the police to breach patient confidentiality and privacy....
Recent evidence suggests that in addition to softer stools, bone mineral content at four months may be increased in infants fed sn-2 palmitate enriched formula. The Béghin (et al) study helps us...
Following ECCO 2021, Stefan Schreiber, MD, Ph.D., Prof. Dr. Rieke Alten, and president of ECCO Laurent Peyrin-Biroulet, MD, Ph.D. discussed the latest developments and findings in Gastroenterology...
The IL-23 pathway, its role in (early) psoriatic arthritis, and the use of imaging techniques to support the diagnosis and management of the disease, were discussed in a Janssen-sponsored satellite...
Following EULAR 2021, Prof. Dr. med Gerd Burmester and Prof. Dr. Sebastian Zeissig discussed the latest developments and findings in rheumatology and gastroenterology, and review highlights of the...
PIK3CA mutations are present in approximately 40% of HR+ tumours.1 In clinical trials in women with HR+/HER2– advanced breast cancer, the frequency of PIK3CA mutations was 33–43%.2–4 SOLAR-1, a...
Advances in management have greatly improved outcomes for women with early breast cancer and drug treatment has replaced surgery as the primary treatment option for many patients.1 Advanced breast...